Quick Dispatch:
Your retatrutide trial data Eli Lilly infiltrates anti-obesity market as Phase III trial for retatrutide begins orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your retatrutide trial data Eli Lilly infiltrates anti-obesity market as Phase III trial for retatrutide begins ships.
Need Help?
Questions about retatrutide trial data Eli Lilly infiltrates anti-obesity market as Phase III trial for retatrutide begins, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for retatrutide trial data Eli Lilly infiltrates anti-obesity market as Phase III trial for retatrutide begins in your area.
First Retatrutide phase 3 data, a Triumph of Science!
27.00
Early trial data for retatrutide demonstrates exceptional weight loss results, reaching approximately 21% placebo-adjusted weight loss by week 48. This performance significantly exceeds all other leading obesity medications currently under
28.29
Today we shared new results on retatrutide, an investigational, first-of-its-kind treatment we're studying in adults with obesity or overweight with at least one weight-related comorbidity. Read more about the Phase 3 findings:
24.84
Retatrutide, an Amazing Future for Weight Loss
27.48
Retatrutide Weight Loss Results Trial Data and FDA Status
26.16
Retatrutide just delivered the first top-line Phase 3 results for a triple agonist in obesity — and the findings from TRIUMPH-4 are striking👇
25.01
Retatrutide just delivered the most powerful weight loss data ever recorded in a Phase 3 obesity trial. At 104 weeks, participants on the 12 mg dose lost an average of 85 pounds
20.15
